Latest Period
Q1 2026
Security Snapshot
Humacyte, Inc. - Common Stock, par value $0.0001 per share (HUMA) Institutional Ownership
CUSIP: 44486Q103
13F Institutional Holders and Ownership History from Q3 2021 to Q2 2026
Institutions Reporting
156
Shares (Excl. Options)
58,856,823
Price
$0.61
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- HUMA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 58,856,823
- Total 13F value
- $35,722,631
- Portfolio coverage rank
- 0%
- Share change
- +3,531,217
- Value change
- +$725,386
- Number of holders
- 156
- Shares outstanding
- 269,769,473
- SEC-reported price per share
- $0.78
- Insider filing price
- $0.78
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 44486Q103.
- 156 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 156 to 15 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $35,722,631 to $406,384.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 156 institutions filings for Q1 2026.
Security key
44486Q103
Latest holder period
Q1 2026
13F holders
156
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
HUMA full holder history
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Humacyte, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 44486Q103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
HUMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 4.7% | $16,367,453 | 12,787,073 | Davidson Kempner Capital Management LP | 12 Jun 2026 |
As of 31 Mar 2026, 156 institutional investors reported holding 58,856,823 shares of Humacyte, Inc. - Common Stock, par value $0.0001 per share (HUMA). This represents 22% of the company’s total 269,769,473 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
20%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.6% | 12,316,955 | +8.6% | 0% | $7,472,696 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7% | 7,158,162 | 0% | 0% | $4,345,004 |
| ANTIPODES PARTNERS Ltd | 2.1% | 5,723,750 | +49039% | 0.07% | $3,472,599 |
| GREAT POINT PARTNERS LLC | 1.4% | 3,750,000 | 0.56% | $2,275,125 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 3,658,108 | -1.7% | 0% | $2,219,881 |
| STATE STREET CORP | 1.1% | 3,043,929 | +7.3% | 0% | $1,846,752 |
| UBS Group AG | 1% | 2,782,070 | -6.6% | 0% | $1,688,716 |
| Woodline Partners LP | 0.74% | 2,002,582 | +0.03% | 0% | $1,214,967 |
| AQR CAPITAL MANAGEMENT LLC | 0.71% | 1,924,691 | +5590% | 0% | $1,167,710 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.53% | 1,417,825 | 0% | 0% | $860,620 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.48% | 1,291,345 | +4.2% | 0% | $783,459 |
| NORTHERN TRUST CORP | 0.45% | 1,223,908 | +6.7% | 0% | $742,546 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.39% | 1,058,048 | +4.8% | 0% | $641,918 |
| VANGUARD FIDUCIARY TRUST CO | 0.37% | 1,011,029 | 0% | 0% | $613,695 |
| LPL Financial LLC | 0.32% | 864,463 | +3.2% | 0% | $524,470 |
| Private Advisor Group, LLC | 0.31% | 832,799 | +48% | 0% | $505,264 |
| GOLDMAN SACHS GROUP INC | 0.25% | 677,015 | +58% | 0% | $410,745 |
| Lion Point Capital, LP | 0.24% | 650,000 | +30% | 2.4% | $394,355 |
| XTX Topco Ltd | 0.15% | 412,090 | -37% | 0% | $250,015 |
| BANK OF AMERICA CORP /DE/ | 0.15% | 396,113 | -12% | 0% | $240,045 |
| Bank of New York Mellon Corp | 0.13% | 353,410 | +2.8% | 0% | $214,414 |
| Nuveen, LLC | 0.13% | 349,435 | +34% | 0% | $212,002 |
| LJI Wealth Management, LLC | 0.1% | 277,500 | -10% | 0.03% | $168,359 |
| IEQ CAPITAL, LLC | 0.1% | 264,319 | 0% | $160,363 | |
| GSA CAPITAL PARTNERS LLP | 0.09% | 249,856 | 0.01% | $152,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 528,712 | $406,384 | +$68,523 | $0.78 | 15 |
| 2026 Q1 | 58,856,823 | $35,722,631 | +$725,386 | $0.61 | 156 |
| 2025 Q4 | 55,385,756 | $53,205,316 | +$7,815,206 | $0.96 | 146 |
| 2025 Q3 | 45,803,224 | $79,706,858 | -$20,549,961 | $1.74 | 138 |
| 2025 Q2 | 56,964,566 | $119,040,607 | -$1,729,485 | $2.09 | 155 |
| 2025 Q1 | 60,715,449 | $103,532,553 | +$24,167,009 | $1.70 | 162 |
| 2024 Q4 | 42,106,165 | $212,715,890 | +$30,515,138 | $5.05 | 161 |
| 2024 Q3 | 35,792,230 | $194,660,626 | +$23,757,191 | $5.44 | 143 |
| 2024 Q2 | 31,200,014 | $149,783,918 | +$47,689,218 | $4.80 | 120 |
| 2024 Q1 | 23,275,197 | $72,382,833 | +$17,071,734 | $3.11 | 95 |
| 2023 Q4 | 17,820,871 | $50,656,070 | +$3,312,296 | $2.84 | 87 |
| 2023 Q3 | 16,610,977 | $48,671,458 | +$5,715,520 | $2.93 | 83 |
| 2023 Q2 | 14,729,897 | $42,225,781 | +$7,517,496 | $2.86 | 75 |
| 2023 Q1 | 12,062,725 | $37,417,372 | +$154,698 | $3.09 | 68 |
| 2022 Q4 | 11,918,522 | $25,143,027 | -$3,006,763 | $2.11 | 71 |
| 2022 Q3 | 11,840,854 | $38,602,556 | -$5,136,200 | $3.26 | 68 |
| 2022 Q2 | 13,437,579 | $43,130,190 | +$8,049,232 | $3.21 | 75 |
| 2022 Q1 | 10,487,756 | $73,993,016 | +$6,152,869 | $7.06 | 69 |
| 2021 Q4 | 9,522,696 | $69,016,600 | +$7,310,797 | $7.25 | 58 |
| 2021 Q3 | 4,907,194 | $56,957,000 | +$56,946,000 | $11.61 | 31 |